DEEPGEN
Commercial- Indications
- Cancer detection
Company intelligence / Profile preview
Quantgene
Santa Monica, California, United Statesquantgene.com ↗
- Ownership
- Private
- Employees
- ~55
- Development stage
- Commercial
01
Overview
Quantgene has developed a proprietary single-molecule precision sequencing technology ("DeepGen") to detect traces of tumor DNA in blood using liquid biopsy. Their multi-cancer early detection approach has been validated in large clinical feasibility trials covering at least fifteen major cancers. The company also offers hereditary cancer testing and pharmacogenomic profiling. Their solutions are deployed both directly to consumers/patients through the Serenity program and within hospitals via the Qi platform. Peer-reviewed publications have demonstrated high accuracy for early-stage detection.
- Therapeutic areas
- OncologyCardiovascular
- Modalities
- Genomics-based diagnosticsLiquid biopsy (cell-free DNA analysis)Artificial intelligence-powered diagnosticsPlatform
- Industry
- Molecular Diagnostics
02
Drug pipeline
2 assets1 more asset in the full pipeline.
Request access →03
Partnerships
Hospital systems piloting or deploying Qi solution ($200M active deal pipeline)
Beyond the preview
Go deeper on Quantgene.
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Licensing & deals
Full profile accessExplore licensing agreements, acquisitions, and the assets behind each deal.
- Partners
- Deal terms
- Milestones
Funding history
Full profile accessTrace financing activity and the investors behind a company’s development.
- Funding rounds
- Investors
- Capital raised
Competitive landscape
Full profile accessCompare peer pipelines by target, modality, and therapeutic area.
- Peer companies
- Targets
- Pipeline overlap
Technologies & patents
Full profile accessExplore technology platforms and the patent landscape around relevant assets.
- Platforms
- Patents
- Assignees
Research & analysis
Full profile accessConnect company news and source material to the questions you’re investigating.
- Company news
- Sources
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Quantgene.